A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Idiopathic nephrotic syndrome in children
Noone, D. G., Iijima, K., & Parekh, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30536-1 · Cited by 586
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
“Of note, other clinical terms are used to describe the same or similar diseases based on age of onset or response to therapy (eg, congenital nephrotic syndrome, steroid resistant nephrotic syndrome).(381) There are case reports of individuals who have developed FSGS, proteinuria and kidney failure after donating a kid…”
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Self-citationVivarelli, M., Massella, L., Ruggiero, B., & Emma, F. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05000516 · Cited by 557
Focal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
Mitochondrial dysfunction in inherited renal disease and acute kidney injury
Emma, F., Montini, G., Parikh, S. M., & Salviati, L. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.214 · Cited by 398
Exploring the genetic basis of early-onset chronic kidney disease
Vivante, A., & Hildebrandt, F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.205 · Cited by 344
Self-citationDifferentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
De Vriese, A. S., Sethi, S., Nath, K. A., Glassock, R. J., & Fervenza, F. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017090958 · Cited by 318
Mitochondrial disorders of the OXPHOS system
Fernandez‐Vizarra, E., & Zeviani, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.13995 · Cited by 305
Floege, J., & Amann, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00272-5 · Cited by 306
Trautmann, A., Boyer, O., Hodson, E., Bagga, A., Gipson, D. S., Samuel, S., Wetzels, J., Alhasan, K., Banerjee, S., Bhimma, R., et al. (2023) · Pediatric Nephrology · doi:10.1007/s00467-022-05739-3 · Cited by 292
“Infantile onset NS About 50% of children with infantile onset NS (age 3–12 months) have a genetic cause of NS which usually does not respond to PDN treatment [31, 32].”
BackgroundSelf-citationBierzynska, A., McCarthy, H. J., Soderquest, K., Sen, E. S., Colby, E., Ding, W. Y., Nabhan, M. M., Kerecuk, L., Hegde, S., Hughes, D., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.013 · Cited by 297
Gast, C., Pengelly, R. J., Lyon, M., Bunyan, D. J., Seaby, E. G., Graham, N., Venkat-Raman, G., & Ennis, S. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv325 · Cited by 254
“D I S C U S S I O N We designed a customized NGS panel for the investigation of FSGS/SRNS, which is the first comprehensive FSGS gene panel in an adult cohort.”
BackgroundInfluentialThe glomerular filtration barrier: a structural target for novel kidney therapies
Daehn, I. S., & Duffield, J. S. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00242-0 · Cited by 245
Mechanisms of podocyte injury and implications for diabetic nephropathy
Barutta, F., Bellini, S., & Gruden, G. (2022) · Clinical Science · doi:10.1042/cs20210625 · Cited by 221
“Several mutated genes causing FSGS regulate the actin cytoskeleton and/or its attachment at GBM [162,163].”
Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome
Warejko, J. K., Tan, W., Daga, A., Schapiro, D., Lawson, J. A., Shril, S., Lovric, S., Ashraf, S., Rao, J., Hermle, T., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04120417 · Cited by 232
Self-citationLong-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children
Trautmann, A., Schnaidt, S., Lipska-Ziętkiewicz, B. S., Bodria, M., Ozaltin, F., Emma, F., Anarat, A., Melk, A., Azocar, M., Oh, J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101121 · Cited by 227
Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly
Braun, D. A., Rao, J., Mollet, G., Schapiro, D., Daugeron, M.-C., Tan, W., Gribouval, O., Boyer, O., Revy, P., Jobst-Schwan, T., et al. (2017) · Nature Genetics · doi:10.1038/ng.3933 · Cited by 220
Self-citationMutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome
Braun, D. A., Sadowski, C. E., Kohl, S., Lovric, S., Astrinidis, S. A., Pabst, W. L., Gee, H. Y., Ashraf, S., Lawson, J. A., Shril, S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3512 · Cited by 213
“By high-throughput exon sequencing 11,14,15 in a worldwide cohort of 1,800 families with SRNS we detected 3 additional families (A2403, A3256, and A1394) with compound heterozygous truncating mutations or highly conserved missense mutations of NUP93 (Table 1, Fig.”
Self-citationGenetic testing in steroid-resistant nephrotic syndrome: when and how?
Lovric, S., Ashraf, S., Tan, W., & Hildebrandt, F. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv355 · Cited by 210
“We also detected founder mutations that had a higher occurrence rate in certain regions of the world [49].”
BackgroundMethodResultInfluentialSelf-citationMinimal change disease and idiopathic FSGS: manifestations of the same disease
Maas, R. J., Deegens, J. K., Smeets, B., Moeller, M. J., & Wetzels, J. F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.147 · Cited by 207
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency
Lovric, S., Goncalves, S., Gee, H. Y., Oskouian, B., Srinivas, H., Choi, W.-I., Shril, S., Ashraf, S., Tan, W., Rao, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89626 · Cited by 205
“Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate.”
Self-citationWhole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study
Lata, S., Marasa, M., Li, Y., Fasel, D. A., Groopman, E., Jobanputra, V., Rasouly, H., Mitrotti, A., Westland, R., Verbitsky, M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1319 · Cited by 203
van der Ven, A. T., Connaughton, D. M., Ityel, H., Mann, N., Nakayama, M., Chen, J., Vivante, A., Hwang, D.-Y., Schulz, J., Braun, D. A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017121265 · Cited by 204
Self-citationKANK deficiency leads to podocyte dysfunction and nephrotic syndrome
Gee, H. Y., Zhang, F., Ashraf, S., Kohl, S., Sadowski, C. E., Vega-Warner, V., Zhou, W., Lovric, S., Fang, H., Nettleton, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79504 · Cited by 194
Self-citationRovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.008 · Cited by 185
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice
Knoers, N., Antignac, C., Bergmann, C., Dahan, K., Giglio, S., Heidet, L., Lipska-Ziętkiewicz, B. S., Noris, M., Remuzzi, G., Vargas-Poussou, R., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab218 · Cited by 173
Bullich, G., Domingo-Gallego, A., Vargas, I., Ruiz, P., Lorente-Grandoso, L., Furlano, M., Fraga, G., Madrid, Á., Ariceta, G., Borregán, M., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.02.027 · Cited by 159
Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients
Mann, N., Braun, D. A., Amann, K., Tan, W., Shril, S., Connaughton, D. M., Nakayama, M., Schneider, R., Kitzler, T. M., van der Ven, A. T., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018060575 · Cited by 157
Self-citationFocal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective
Shabaka, A., Tato, A., & Juarez, G. M. F. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000508099 · Cited by 186
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Hodson, E. M., Wong, S., Willis, N. S., & Craig, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003594.pub5 · Cited by 149
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis
Braun, D. A., Lawson, J. A., Gee, H. Y., Halbritter, J., Shril, S., Tan, W., Stein, D. R., Wassner, A. J., Ferguson, M. A., Gucev, Z. S., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07540715 · Cited by 155
Self-citationBüscher, A. K., Beck, B. B., Melk, A., Hoefele, J., Kranz, B., Bamborschke, D., Baig, S., Lange-Sperandio, B., Jungraithmayr, T., Weber, L. T., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07370715 · Cited by 148
Self-citationGenetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
Preston, R., Stuart, H. M., & Lennon, R. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3838-6 · Cited by 159
“hood of finding causative recessive mutations correlates directly with the degree of consanguinity [80]; thus, a history of consanguinity should prompt mutational screening.”
BackgroundVivarelli, M., Gibson, K. L., Sinha, A. P., & Boyer, O. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01051-6 · Cited by 141
Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome
Braun, D. A., Lovric, S., Schapiro, D., Schneider, R., Marquez, J., Asif, M., Hussain, M. S., Daga, A., Widmeier, E., Rao, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98688 · Cited by 148
“We therefore performed targeted sequencing of all exons of 19 genes that encode other NUPs in a worldwide cohort of 2,164 families with SRNS using a multiplex PCR–based high-throughput sequencing strategy (7, 30, 31) or using whole exome sequencing.”
Self-citationGenomic medicine for kidney disease
Groopman, E., Rasouly, H. M., & Gharavi, A. G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.167 · Cited by 153
FAT1 mutations cause a glomerulotubular nephropathy
Gee, H. Y., Sadowski, C. E., Aggarwal, P. K., Porath, J. D., Yakulov, T. A., Schueler, M., Lovric, S., Ashraf, S., Braun, D. A., Halbritter, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10822 · Cited by 138
Self-citationTrautmann, A., Lipska-Ziętkiewicz, B. S., & Schaefer, F. S. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00200 · Cited by 128
Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment
Ashraf, S., Kudo, H., Rao, J., Kikuchi, A., Widmeier, E., Lawson, J. A., Tan, W., Hermle, T. F., Warejko, J. K., Shril, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04193-w · Cited by 131
Self-citationMiyake, N., Tsukaguchi, H., Koshimizu, E., Shono, A., Matsunaga, S., Shiina, M., Mimura, Y., Imamura, S., Hirose, T., Okudela, K., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.08.013 · Cited by 124
Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players
Domingo-Gallego, A., Pybus, M., Bullich, G., Furlano, M. M., Ejarque, L., Lorente, L., Ruíz, P., Fraga, G. M., González, M. L., Piñero‐Fernández, J. A., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab019 · Cited by 126
Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome
Wang, F., Zhang, Y., Mao, J., Yu, Z., Yi, Z.-W., Li, Y., Sun, J., Wei, X., Ding, F., Zhang, H., et al. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3590-y · Cited by 122
“As in children of other ethnicities with SRNS, the percentage of detecting diseasecausing mutations decreased as the age at onset of NS increased in the present study [12, 16, 17].”
BackgroundResultSelf-citationNew Insights into Podocyte Biology in Glomerular Health and Disease
Assady, S., Wanner, N., Skorecki, K. L., & Huber, T. B. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010027 · Cited by 112
Rinschen, M. M., Gödel, M., Grahammer, F., Zschiedrich, S., Helmstädter, M., Kretz, O., Zarei, M., Braun, D. A., Dittrich, S., Pahmeyer, C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.059 · Cited by 105
Self-citationBoyer, O., Schaefer, F. S., Haffner, D., Böckenhauer, D., Hölttä, T., Bérody, S., Webb, H., Heselden, M., Lipska-Ziętkiewicz, B. S., Özaltın, F., et al. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00384-1 · Cited by 120
Braun, D. A., Schueler, M., Halbritter, J., Gee, H. Y., Porath, J. D., Lawson, J. A., Airik, R., Shril, S., Allen, S. J., Stein, D. R., et al. (2015) · Kidney International · doi:10.1038/ki.2015.317 · Cited by 118
Self-citationHypertension-attributed nephropathy: what's in a name?
Freedman, B. I., & Cohen, A. H. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.172 · Cited by 109
Ashton, E., Legrand, A., Benoît, V., Roncelin, I., Vénisse, A., Zennaro, M., Jeunemaı̂tre, X., Iancu, D., Hoff, W. V., Walsh, S. B., et al. (2018) · Kidney International · doi:10.1016/j.kint.2017.10.016 · Cited by 102
Clinical syndromes associated with Coenzyme Q10 deficiency
Alcázar-Fabra, M., Trevisson, E., & Brea-Calvo, G. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170107 · Cited by 96
“It is worth to mention that most of the COQ6 patients were diagnosed during screening for SNRS, so there may be a reference bias in these cases (71,107,109).”
Molecular stratification of idiopathic nephrotic syndrome
Saleem, M. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0217-5 · Cited by 111
Mallett, A. J., McCarthy, H. J., Ho, G., Holman, K. J., Farnsworth, E., Patel, C., Fletcher, J. T., Mallawaarachchi, A. C., Quinlan, C., Bennetts, B., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.06.013 · Cited by 105
Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome
Landini, S., Mazzinghi, B., Becherucci, F., Allinovi, M., Provenzano, A., Palazzo, V., Ravaglia, F., Artuso, R., Bosi, E., Stagi, S., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06060519 · Cited by 100
Personalized medicine in chronic kidney disease by detection of monogenic mutations
Connaughton, D. M., & Hildebrandt, F. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz028 · Cited by 98
“5% of SRNS cases, with onset before 25 years, a causative mutation can be detected [16].”
BackgroundSelf-citationModeling Monogenic Human Nephrotic Syndrome in the Drosophila Garland Cell Nephrocyte
Hermle, T. F., Braun, D. A., Helmstädter, M., Huber, T. B., & Hildebrandt, F. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050517 · Cited by 93
Self-citationRao, J., Liu, X., Mao, J., Tang, X., Shen, Q., Li, G., Sun, L., Bi, Y., Wang, X., Qian, Y., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13606 · Cited by 93
“In our cohort, the genetic diagnostic rate was 32.1% among patients with SRNS which is similar to the previous reports from the international pediatric cohort of SRNS.10,11 The subgroup of SRNS in this study included 1/3 cases of early-onset age group.”
BackgroundResultInfluentialIncidence and Relapse of Idiopathic Nephrotic Syndrome: Meta-analysis
Veltkamp, F., Rensma, L. R., & Bouts, A. H. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-029249 · Cited by 108
The glomerular permeability factors in idiopathic nephrotic syndrome
Davin, J. C. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3082-x · Cited by 94
Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach
Yu, S. M.-W., Nissaisorakarn, P., Husain, I., & Jim, B. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00221 · Cited by 87
Lepori, N., Zand, L., Sethi, S. M., Juarez, G. M. F., & Fervenza, F. C. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfx143 · Cited by 95
“NPHS2 is the gene most frequently involved, with an autosomal recessive pattern of inheritance and a reported prevalence that ranges from 4% to 30% in familial cases [30, 31, 44, 48] and from 0 to 11% in sporadic cases [30, 31, 44, 45, 48].”
BackgroundMAGI2 Mutations Cause Congenital Nephrotic Syndrome
Bierzynska, A., Soderquest, K., Dean, P., Colby, E., Rollason, R., Jones, C., Inward, C. D., McCarthy, H. J., Simpson, M. A., Lord, G. M., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040387 · Cited by 82
The Paradox of Coenzyme Q10 in Aging
Díaz-Casado, M. E., Quiles, J. L., Barriocanal-Casado, E., González-García, P., Battino, M., López, L. C., & Varela-López, A. (2019) · Nutrients · doi:10.3390/nu11092221 · Cited by 81
“(a) Schematic model of ma malian cells CoQ biosynthesis t : - ic acid (4HB) is the ring precursor, dimethylally pyrophosphate (DMAP ) and isopentenyl pyrophosphate (IPP) are precurso to form polyprenyl diphosphate via prenyldiphosphate synthase ub nit (PDSS)1/PDSS2.”
InfluentialJanecke, A., Xu, R., Steichen‐Gersdorf, E., Waldegger, S., Entenmann, A., Giner, T., Krainer, I. M., Huber, L. A., Hess, M. W., Frishberg, Y., et al. (2017) · Human Mutation · doi:10.1002/humu.23192 · Cited by 86
“…than 30 genes that cause CNS when mutated, NPHS1 (nephrin; MIM# 602716), NPHS2 (podocin; MIM# 604766), LAMB2 (laminin 𝛽2; MIM# 150325), WT1 (Wilms tumor suppressor 1; MIM# 607102), and PLCE1 (phospholipase C ɛ; MIM# 608414) account for >85% of cases (Sadowski et al., 2015; Trautmann et al., 2015).”
Comprehensive genetic diagnosis of Japanese patients with severe proteinuria
Nagano, C., Yamamura, T., Horinouchi, T., Aoto, Y., Ishiko, S., Sakakibara, N., Shima, Y., Nakanishi, K., Nagase, H., Iijima, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57149-5 · Cited by 80
Wang, Y., Lilienfeldt, N., & Hekimi, S. (2024) · Physiological Reviews · doi:10.1152/physrev.00040.2023 · Cited by 103
Sen, E. S., Dean, P., Yarram-Smith, L., Bierżyńska, A., Woodward, G., Buxton, C., Dennis, G., Welsh, G. I., Williams, M., & Saleem, M. A. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104811 · Cited by 88
Complement Activation in Patients with Focal Segmental Glomerulosclerosis
Thurman, J. M., Wong, M., Renner, B., Frazer‐Abel, A. A., Giclas, P. C., Joy, M. S., Jalal, D. I., Radeva, M., Gassman, J., Gipson, D. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136558 · Cited by 77
“Mutations in podocyte proteins have been identified as monogenic causes of disease in nearly 30% of patients with steroid resistant FSGS [2].”
BackgroundThe expanding phenotypic spectra of kidney diseases: insights from genetic studies
Stokman, M. F., Renkema, K. Y., Giles, R. H., Schaefer, F. S., Knoers, N. V. A. M., & van Eerde, A. M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.87 · Cited by 86
“In a cohort of 61 patients with WT1 -related SRNS, truncating mutations were associated with a high risk of developing Wilms tumour (78”
InfluentialIdentification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults
Gribouval, O., Boyer, O., Hummel, A., Dantal, J., Martinez, F., Sberro‐Soussan, R., Étienne, I., Chauveau, D., Delahousse, M., Lionet, A., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.07.024 · Cited by 76
From podocyte biology to novel cures for glomerular disease
Torban, E., Braun, F., Wanner, N., Takano, T., Goodyer, P., Lennon, R., Ronco, P. M., Cybulsky, A. V., & Huber, T. B. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.015 · Cited by 76
Trachtman, H., Vento, S., Herreshoff, E. G., Radeva, M., Gassman, J., Stein, D. T., Savin, V. J., Sharma, M., Reiser, J., Wei, C., et al. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0094-5 · Cited by 74
“The key inclusion criteria were: (1) primary FSGS confirmed by renal biopsy or by documented history of a disease-causing mutation [3]; (2) failure to respond to prior therapy with corticosteroids and at least one other immunosuppressive medication; (3) age 1–50 years at onset of proteinuria and 1–51 years at time of…”
BackgroundSelf-citationClinical Genetic Screening in Adult Patients with Kidney Disease
Cocchi, E., Nestor, J. G., & Gharavi, A. G. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15141219 · Cited by 85
Ding, F., Wickman, L. T., Wang, S. Q., Zhang, Y., Wang, F., Afshinnia, F., Hodgin, J. B., Ding, J., & Wiggins, R. C. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.017 · Cited by 74
Genetic testing for kidney disease of unknown etiology
Hays, T., Groopman, E., & Gharavi, A. G. (2020) · Kidney International · doi:10.1016/j.kint.2020.03.031 · Cited by 79
Jia, X., Horinouchi, T., Hitomi, Y., Shono, A., Khor, S., Omae, Y., Kojima, K., Kawai, Y., Nagasaki, M., Kaku, Y., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080859 · Cited by 74
Jia, X., Yamamura, T., Gbadegesin, R., McNulty, M. T., Song, K., Nagano, C., Hitomi, Y., Lee, D., Aiba, Y., Khor, S., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.029 · Cited by 77
“The pathogenesis of INS is still unclear, although more than 50 causative single genes for steroid-resistant nephrotic syndrome have been found, and causative mutations in these genes were identified in approximately 30% of childhood and young adult patients with steroid-resistant nephrotic syndrome.(5,6) Recently, 6…”
BackgroundDing, W. Y., Kuzmuk, V., Hunter, S., Lay, A. C., Hayes, B., Beesley, M., Rollason, R., Hurcombe, J., Barrington, F., Masson, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8226 · Cited by 78
Jinks, R. N., Puffenberger, E. G., Baple, E., Harding, B., Crino, P., Fogo, A. B., Wenger, O., Xin, B., Koehler, A. E., McGlincy, M. H., et al. (2015) · Brain · doi:10.1093/brain/awv153 · Cited by 69
“Cells were then extracted with 10% acetic acid and the absorbance of the extract was measured with a spectrophotometer at 590 nm. Data were analysed using Student’s t-test ( = 0.05) with Microsoft Excel.”
BackgroundMethodInfluentialSelf-citationDrovandi, S., Lipska-Ziętkiewicz, B. S., Özaltın, F., Emma, F., Gülhan, B., Boyer, O., Trautmann, A., Xu, H. M., Shen, Q., Rao, J., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.04.029 · Cited by 77
Treatment and outcome of congenital nephrotic syndrome
Bérody, S., Heidet, L., Gribouval, O., Harambat, J., Niaudet, P., Baudouin, V., Bacchetta, J., Boudaillez, B., Dehennault, M., de Parscau, L., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy015 · Cited by 74
“The underlying defect was biallelic mutations in NPHS1 (36/55, 65%), NPHS2 (5/55, 7%), PLCE1 (1/55, 2%), heterozygous mutation in WT1 (4/55, 7”
BackgroundInfluentialAlcázar‐Fabra, M., Rodríguez‐Sánchez, F., Trevisson, E., & Brea‐Calvo, G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.046 · Cited by 71
Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children
Kamei, K., Ishikura, K., Sako, M., Ito, S., Nozu, K., & Iijima, K. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4166-1 · Cited by 71
Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach
Lamarche, C., Iliuta, I.-A., & Kitzler, T. M. (2019) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358119839080 · Cited by 68
“5% of cases of steroid-resistant nephrotic syndrome.(76) The largest and most recent study to date demonstrated that exome sequencing in a combined cohort of more than 3000 patients with CKD yielded a diagnosis in 10% of patients.”
BackgroundKomers, R., Diva, U., Inrig, J. K., Loewen, A., Trachtman, H., & Rote, W. E. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.017 · Cited by 69
“Genetic causes include mutations in genes encoding proteins required for normal podocyte structure and/or function.(5) In contrast, secondary forms of FSGS are caused by loss of renal parenchyma, metabolic derangements, other antecedent diseases, drugs, or infections.”
BackgroundThe Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease
Raina, R., Chauvin, A. M., Chakraborty, R., Nair, N., Shah, H., Krishnappa, V., & Kusumi, K. (2019) · Kidney Diseases · doi:10.1159/000504623 · Cited by 62
Beck, L. H., Ayoub, I. M., Caster, D. J., Choi, M. J., Cobb, J., Geetha, D., Rheault, M. N., Wadhwani, S., Yau, T. T., & Whittier, W. L. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.02.003 · Cited by 79
“Between 11% and 30% of children with steroid-resistant disease will have a monogenic cause of disease.(59,60) A clear recommendation from the KDIGO Work Group for genetic testing in this population is needed to support insurance coverage and family acceptance of genetic testing in these situations.”
BackgroundThomas, C. P., Daloul, R., Lentine, K. L., Gohh, R., Anand, P. M., Rasouly, H. M., Sharfuddin, A., Schlöndorff, J. S., Rodig, N., Freese, M. E., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.02.020 · Cited by 66
Genomic approaches for understanding dengue: insights from the virus, vector, and host
Sim, S., & Hibberd, M. L. (2016) · Genome biology · doi:10.1186/s13059-016-0907-2 · Cited by 74
“Mutations in PLCE1 are also associated with nephrotic syndrome [157, 158], a childhood kidney disorder in”
BackgroundRecurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas
Uffing, A., Hullekes, F. E., Riella, L. V., & Hogan, J. J. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00280121 · Cited by 62
Osafo, C., Raji, Y. R., Burke, D., Tayo, B. O., Tiffin, N., Moxey‐Mims, M., Rasooly, R. S., Kimmel, P. L., OJO, A. O., Adu, D., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11951214 · Cited by 60
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis
Yu, H., Artomov, M., Brähler, S., Stander, M. C., Shamsan, G., Sampson, M. G., White, J. M., Kretzler, M., Miner, J. H., Jain, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82592 · Cited by 59
“org Volume 126 Number 3 March 2016 25 have a variant in one of the known disease genes (38).”
Trpc6 inactivation confers protection in a model of severe nephrosis in rats
Kim, E. Y., Shotorbani, P. Y., & Dryer, S. E. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1648-3 · Cited by 59
“Familial FSGS associated with Trpc6 mutations is rare [10], and it is not known if dysregulation of wild-type”
BackgroundEfficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome
Ahn, Y. H., Kim, S. H., Han, K. H., Choi, H. J., Cho, H., Lee, J. W., Shin, J. I., Cho, M. H., Lee, J. H., Park, Y. S., et al. (2018) · Medicine · doi:10.1097/md.0000000000013157 · Cited by 59
Genetic Disorders of the Glomerular Filtration Barrier
Li, A. S., Ingham, J. F., & Lennon, R. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11440919 · Cited by 59
Long-term Outcomes of Childhood Onset Nephrotic Syndrome
Hjorten, R. C., Anwar, Z., & Reidy, K. J. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00053 · Cited by 58
“A single-gene mutation may be identified in up to 29% of patients with SRNS onset prior to age 25 (38).”
BackgroundDominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children
Vivante, A., Staretz‐Chacham, O., Shril, S., Schreiber, R., Mane, S., Pode‐Shakked, B., Soliman, N. A., Koneth, I., Schiffer, M., Anikster, Y., et al. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04256-0 · Cited by 58
Self-citationContributions of Rare Gene Variants to Familial and Sporadic FSGS
Wang, M., Chun, J., Genovese, G., Knob, A. U., Benjamin, A., Wilkins, M. S., Friedman, D. J., Appel, G. B., Lifton, R. P., Mane, S., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020152 · Cited by 62
Self-citationAdvillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome
Rao, J., Ashraf, S., Tan, W., van der Ven, A. T., Gee, H. Y., Braun, D. A., Fehér, K., George, S. P., Esmaeilniakooshkghazi, A., Choi, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94138 · Cited by 52
“We have recently shown in a cohort of 1,780 families with SRNS that 30% of all cases are caused by mutations in 1 of the 26 genes known at the time to cause SRNS (13).”
BackgroundSelf-citationMitochondrial Disease and the Kidney With a Special Focus on CoQ10 Deficiency
Schijvens, A. M., van de Kar, N. C. A. J., Bootsma-Robroeks, C. M., Cornelissen, E. A. M., van den Heuvel, L. P., & Schreuder, M. F. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.09.044 · Cited by 59
Labat‐de‐Hoz, L., & Alonso, M. A. (2021) · Cells · doi:10.3390/cells10102554 · Cited by 63
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.